Cargando…
Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
Objective: Access to medicines has long been and remains a challenge in African countries. The impact of medicines registration policies in these countries poses a challenge for pharmaceutical companies wanting to register medicines in these countries. The recent AMRHI (African Medicines Registratio...
Autores principales: | Narsai, Kirti, Williams, Abeda, Mantel-Teeuwisse, Aukje Kaija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dr. Zaheer-Ud-Din Babar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471191/ https://www.ncbi.nlm.nih.gov/pubmed/23093897 |
Ejemplares similares
-
Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010) -
Linking market authorizations of medicines with disease burden in South Africa
por: Narsai, K., et al.
Publicado: (2021) -
Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020) -
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014) -
Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal
por: Samukange, Washington T., et al.
Publicado: (2021)